Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nurix Therapeutics Inc
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Total Current Assets
$295.5m
CAGR 3-Years
0%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Assets
$33.8B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
7%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$12.3B
CAGR 3-Years
-4%
CAGR 5-Years
-18%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$27.2B
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$8.9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$19.1B
CAGR 3-Years
13%
CAGR 5-Years
23%
CAGR 10-Years
26%

See Also

What is Nurix Therapeutics Inc's Total Current Assets?
Total Current Assets
295.5m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Total Current Assets amounts to 295.5m USD.

What is Nurix Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
49%

Over the last year, the Total Current Assets growth was -7%.

Back to Top